TrialThe Journal of infectious diseases2014

Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection.

Netanya G Sandler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.